Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Reimbursement

    Value-Based Care(VBC)

    In one line
    Payment tied to outcomes and total cost of care, not volume of services.
    Definition
    Value-based care models - ACOs, bundled payments, capitation, shared savings - link payment to quality and total-cost-of-care performance instead of fee-for-service volume. The CMS Innovation Center (CMMI) tests many value-based models, and the Medicare Shared Savings Program is the largest ACO program. In these models a device is judged by its effect on total cost and outcomes, such as fewer readmissions, rather than its price alone. Health economic models and real-world outcomes data become key sales tools.
    Why it matters
    Devices that reduce readmissions, length of stay, or downstream complications align well with VBC. Devices that add cost without measurable outcome benefit are squeezed.
    Common pitfalls
    • •Misinterpreting that value-based care allows for relaxed regulatory compliance for devices; all regulations still apply.
    • •Assuming that demonstrating cost-effectiveness alone is sufficient for a device without proving safety and performance through established regulatory pathways.
    • •Failing to collect robust real-world evidence of a device's impact on patient outcomes and total cost of care, which is crucial for demonstrating value.
    • •Designing devices without considering their usability and data integration capabilities within hospital systems and care pathways operating under value-based agreements.
    • •Neglecting to consider the cybersecurity implications of increased data sharing and interoperability required for value-based care models, which could expose patient data or compromise device functionality.
    Sources
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.